Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.
2.

An international registry of patients with plasminogen deficiency (HISTORY).

Shapiro AD, Menegatti M, Palla R, Boscarino M, Roberson C, Lanzi P, Bowen J, Nakar C, Janson IA, Peyvandi F.

Haematologica. 2020 Mar;105(3):554-561. doi: 10.3324/haematol.2019.241158. Epub 2020 Jan 30. Review.

3.

Management of rare acquired bleeding disorders.

Menegatti M, Biguzzi E, Peyvandi F.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):80-87. doi: 10.1182/hematology.2019000066.

PMID:
31808848
4.

Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease.

Paraboschi EM, Khera AV, Merlini PA, Gigante L, Peyvandi F, Chaffin M, Menegatti M, Busti F, Girelli D, Martinelli N, Olivieri O, Kathiresan S, Ardissino D, Asselta R, Duga S.

Haematologica. 2019 Nov 7. pii: haematol.2019.237750. doi: 10.3324/haematol.2019.237750. [Epub ahead of print]

5.

Unfolding political attitudes through the face: facial expressions when reading emotion language of left- and right-wing political leaders.

Fino E, Menegatti M, Avenanti A, Rubini M.

Sci Rep. 2019 Oct 30;9(1):15689. doi: 10.1038/s41598-019-51858-7. Erratum in: Sci Rep. 2020 Feb 5;10(1):2275.

6.

Clinical and laboratory diagnosis of rare coagulation disorders (RCDs).

Menegatti M, Palla R.

Thromb Res. 2019 Sep 7. pii: S0049-3848(19)30402-5. doi: 10.1016/j.thromres.2019.09.006. [Epub ahead of print]

PMID:
31515069
7.

Profiling the mutational landscape of coagulation factor V deficiency.

Paraboschi EM, Menegatti M, Rimoldi V, Borhany M, Abdelwahab M, Gemmati D, Peyvandi F, Duga S, Asselta R.

Haematologica. 2020 Apr;105(4):e180-e185. doi: 10.3324/haematol.2019.232587. Epub 2019 Aug 8. No abstract available.

8.

Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis.

Weyand AC, Grzegorski SJ, Rost MS, Lavik KI, Ferguson AC, Menegatti M, Richter CE, Asselta R, Duga S, Peyvandi F, Shavit JA.

Blood Adv. 2019 Jun 11;3(11):1670-1680. doi: 10.1182/bloodadvances.2018029066.

9.

Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency.

Paraboschi EM, Menegatti M, Peyvandi F, Duga S, Asselta R.

Int J Mol Sci. 2019 Feb 20;20(4). pii: E910. doi: 10.3390/ijms20040910.

10.

Controversies and Misconceptions Related to Cerebrospinal Fluid Circulation: A Review of the Literature from the Historical Pioneers' Theories to Current Models.

Mantovani G, Menegatti M, Scerrati A, Cavallo MA, De Bonis P.

Biomed Res Int. 2018 Nov 26;2018:2928378. doi: 10.1155/2018/2928378. eCollection 2018. Review.

11.

Treatment of rare factor deficiencies other than hemophilia.

Menegatti M, Peyvandi F.

Blood. 2019 Jan 31;133(5):415-424. doi: 10.1182/blood-2018-06-820738. Epub 2018 Dec 17. Review.

PMID:
30559262
12.

Newcomb-Benford law and the detection of frauds in international trade.

Cerioli A, Barabesi L, Cerasa A, Menegatti M, Perrotta D.

Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):106-115. doi: 10.1073/pnas.1806617115. Epub 2018 Dec 10.

13.

Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.

Al-Khabori M, Pathare A, Menegatti M, Peyvandi F.

J Thromb Haemost. 2018 Jun;16(6):1052-1054. doi: 10.1111/jth.14126. Epub 2018 May 13.

PMID:
29665207
14.

Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice.

Bellan M, Menegatti M, Ferrari C, Carnevale Schianca GP, Pirisi M.

Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):610-617. doi: 10.1016/j.numecd.2018.01.006. Epub 2018 Feb 2.

PMID:
29656956
15.

Molecular investigation of 41 patients affected by coagulation factor XI deficiency.

Rimoldi V, Paraboschi EM, Menegatti M, Peyvandi F, Salomon O, Duga S, Asselta R.

Haemophilia. 2018 Mar;24(2):e50-e55. doi: 10.1111/hae.13378. Epub 2017 Nov 27. No abstract available.

PMID:
29178608
16.

Minimal factor XIII activity level to prevent major spontaneous bleeds: reply.

Menegatti M, Palla R, Bucciarelli P, Peyvandi F.

J Thromb Haemost. 2017 Nov;15(11):2280-2282. doi: 10.1111/jth.13851. Epub 2017 Oct 9. No abstract available.

17.

Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories.

Jennings I, Kitchen S, Menegatti M, Palla R, Walker I, Peyvandi F, Makris M.

Int J Lab Hematol. 2017 Dec;39(6):653-662. doi: 10.1111/ijlh.12721. Epub 2017 Aug 2.

PMID:
28766854
18.

Minimal factor XIII activity level to prevent major spontaneous bleeds.

Menegatti M, Palla R, Boscarino M, Bucciarelli P, Muszbek L, Katona E, Makris M, Peyvandi F; PRO-RBDD study group.

J Thromb Haemost. 2017 Sep;15(9):1728-1736. doi: 10.1111/jth.13772. Epub 2017 Aug 17.

19.

Exploring the global landscape of genetic variation in coagulation factor XI deficiency.

Asselta R, Paraboschi EM, Rimoldi V, Menegatti M, Peyvandi F, Salomon O, Duga S.

Blood. 2017 Jul 27;130(4):e1-e6. doi: 10.1182/blood-2017-04-780148. Epub 2017 Jun 14.

PMID:
28615222
20.

Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.

Hu Z, Liu Y, Huarng MC, Menegatti M, Reyon D, Rost MS, Norris ZG, Richter CE, Stapleton AN, Chi NC, Peyvandi F, Joung JK, Shavit JA.

Blood. 2017 Aug 3;130(5):666-676. doi: 10.1182/blood-2017-02-765206. Epub 2017 Jun 2.

21.

Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories.

Jennings I, Kitchen S, Menegatti M, Palla R, Walker I, Makris M, Peyvandi F.

Int J Lab Hematol. 2017 Aug;39(4):350-358. doi: 10.1111/ijlh.12633. Epub 2017 Apr 13.

PMID:
28406553
22.

Testosterone Plasma Concentration is Associated with Insulin Resistance in Male Hypertensive Patients.

Schianca GP, Fra GP, Brustia F, Bellan M, Pirovano A, Gualerzi A, Gentile M, Gibbin A, Menegatti M, Bartoli E, Pirisi M.

Exp Clin Endocrinol Diabetes. 2017 Mar;125(3):171-175. doi: 10.1055/s-0042-121492. Epub 2017 Jan 10.

PMID:
28073130
23.

Treatment of rare factor deficiencies in 2016.

Peyvandi F, Menegatti M.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):663-669. Review.

24.

Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders.

Palla R, Siboni SM, Menegatti M, Musallam KM, Peyvandi F; European Network of Rare Bleeding Disorders (EN-RBD) group.

Thromb Res. 2016 Dec;148:128-134. doi: 10.1016/j.thromres.2016.11.008. Epub 2016 Nov 15.

PMID:
27855295
25.

Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.

Naderi M, Tabibian S, Menegatti M, Kalantar E, Kazemi A, Zaker F, Dorgalaleh A.

Blood Coagul Fibrinolysis. 2016 Dec;27(8):933-935.

PMID:
26836269
26.

Enjoying vs. smiling: Facial muscular activation in response to emotional language.

Fino E, Menegatti M, Avenanti A, Rubini M.

Biol Psychol. 2016 Jul;118:126-135. doi: 10.1016/j.biopsycho.2016.04.069. Epub 2016 May 7.

PMID:
27164178
27.

Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.

Colucci M, Incampo F, Cannavò A, Menegatti M, Siboni SM, Zaccaria F, Semeraro N, Peyvandi F.

J Thromb Haemost. 2016 Aug;14(8):1603-14. doi: 10.1111/jth.13342. Epub 2016 Jul 18.

28.

An unusual adverse reaction to iodine-based contrast agent.

Menegatti M, Pirisi M, Bellan M.

Eur J Intern Med. 2016 Jul;32:e5-6. doi: 10.1016/j.ejim.2016.02.007. Epub 2016 Feb 18. No abstract available.

PMID:
26899990
29.

Frequency of the p.Gly262Asp mutation in congenital Factor X deficiency.

Epcacan S, Menegatti M, Akbayram S, Cairo A, Peyvandi F, Oner AF.

Eur J Clin Invest. 2015 Oct;45(10):1087-91. doi: 10.1111/eci.12511. Epub 2015 Sep 2.

PMID:
26222694
30.

Neonatal onset of congenital factor X deficiency: a description of two novel mutations with 6-year follow-up.

Corsini I, Menegatti M, Cairo A, Dani C.

Blood Coagul Fibrinolysis. 2015 Sep;26(6):679-81. doi: 10.1097/MBC.0000000000000305.

PMID:
26083982
31.

Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.

Asselta R, Platè M, Robusto M, Borhany M, Guella I, Soldà G, Afrasiabi A, Menegatti M, Shamsi T, Peyvandi F, Duga S.

Thromb Haemost. 2015 Mar;113(3):567-76. doi: 10.1160/TH14-07-0629. Epub 2014 Nov 27.

PMID:
25427968
32.

Thrombin generation in patients with idiopathic sudden sensorineural hearing loss.

Tripodi A, Capaccio P, Pignataro L, Chantarangkul V, Menegatti M, Bamonti F, Clerici M, De Giuseppe R, Peyvandi F.

Thromb Res. 2014 Jun;133(6):1130-4. doi: 10.1016/j.thromres.2014.03.031. Epub 2014 Mar 21.

PMID:
24690481
33.

Wagner-Meissner-like corpuscles in gastric mucosa: a brief report.

Reale D, Ballotta MR, Borghi L, Lisato LC, Rasi A, Menegatti MT.

Int J Surg Pathol. 2014 Sep;22(6):544-6. doi: 10.1177/1066896914525227. Epub 2014 Feb 28.

PMID:
24583834
34.

A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular trafficking.

Menegatti M, Vangone A, Palla R, Milano G, Cavallo L, Oliva R, De Cristofaro R, Peyvandi F.

Thromb Res. 2014 Mar;133(3):481-7. doi: 10.1016/j.thromres.2013.12.020. Epub 2013 Dec 21.

PMID:
24393662
35.

Genotype and phenotype report on patients with combined deficiency of factor V and factor VIII in Iran.

Karimi M, Cairo A, Safarpour MM, Haghpanah S, Ekramzadeh M, Afrasiabi A, Shahriari M, Menegatti M.

Blood Coagul Fibrinolysis. 2014 Jun;25(4):360-3. doi: 10.1097/MBC.0000000000000046.

PMID:
24389588
36.

Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management.

Peyvandi F, Menegatti M, Palla R.

Semin Thromb Hemost. 2013 Sep;39(6):579-84. doi: 10.1055/s-0033-1349221. Epub 2013 Jul 25. Review.

PMID:
23888434
37.

Optimal choice on prevention and cure: a new economic analysis.

Menegatti M.

Eur J Health Econ. 2014 May;15(4):363-72. doi: 10.1007/s10198-013-0479-y. Epub 2013 Apr 24.

PMID:
23612779
38.

Cocaine abuse and sleep apnea in severe obesity.

Marzullo P, Menegatti M, Guzzaloni G, Fanari P, Uccelli E, Tagliaferri MA, Aimaretti G, Liuzzi A.

J Addict Med. 2013 Jul-Aug;7(4):294-5. doi: 10.1097/ADM.0b013e31828c8196.

PMID:
23519053
39.

Convincing similar and dissimilar others: the power of language abstraction in political communication.

Menegatti M, Rubini M.

Pers Soc Psychol Bull. 2013 May;39(5):596-607. doi: 10.1177/0146167213479404. Epub 2013 Mar 12.

PMID:
23482501
40.

Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders.

Van Geffen M, Menegatti M, Loof A, Lap P, Karimi M, Laros-van Gorkom BA, Brons P, Van Heerde WL.

Haemophilia. 2012 Jul;18(4):630-8. doi: 10.1111/j.1365-2516.2012.02759.x. Epub 2012 Mar 8.

PMID:
22404435
41.

Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes.

Lotta LA, Wang M, Yu J, Martinelli I, Yu F, Passamonti SM, Consonni D, Pappalardo E, Menegatti M, Scherer SE, Lewis LL, Akbar H, Wu Y, Bainbridge MN, Muzny DM, Mannucci PM, Gibbs RA, Peyvandi F.

BMC Med Genomics. 2012 Feb 21;5:7. doi: 10.1186/1755-8794-5-7.

42.

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.

Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, Pergantou H, Platokouki H, Giangrande P, Peerlinck K, Celkan T, Ozdemir N, Bidlingmaier C, Ingerslev J, Giansily-Blaizot M, Schved JF, Gilmore R, Gadisseur A, Benedik-Dolničar M, Kitanovski L, Mikovic D, Musallam KM, Rosendaal FR; European Network of Rare Bleeding Disorders Group.

J Thromb Haemost. 2012 Apr;10(4):615-21. doi: 10.1111/j.1538-7836.2012.04653.x.

43.

Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran.

Eshghi P, Cohan N, Lak M, Naderi M, Peyvandi F, Menegatti M, Karimi M.

Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):100-3. doi: 10.1177/1076029611412363. Epub 2011 Dec 6. Review.

PMID:
22156982
44.

Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran.

Karimi M, Vafafar A, Haghpanah S, Payandeh M, Eshghi P, Hoofar H, Afrasiabi A, Gerdabi J, Ardeshiri R, Menegatti M, Peyvandi F.

Haemophilia. 2012 Mar;18(2):211-5. doi: 10.1111/j.1365-2516.2011.02635.x. Epub 2011 Aug 19.

PMID:
21854511
45.

Gynecological and obstetrical manifestations of inherited bleeding disorders in women.

Peyvandi F, Garagiola I, Menegatti M.

J Thromb Haemost. 2011 Jul;9 Suppl 1:236-45. doi: 10.1111/j.1538-7836.2011.04372.x. Review.

46.

Post-partum hemorrhage in women with rare bleeding disorders.

Peyvandi F, Menegatti M, Siboni SM.

Thromb Res. 2011 Feb;127 Suppl 3:S116-9. doi: 10.1016/S0049-3848(11)70031-7.

PMID:
21262429
47.

Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis.

Vener C, Novembrino C, Catena FB, Fracchiolla NS, Gianelli U, Savi F, Radaelli F, Fermo E, Cortelezzi A, Lonati S, Menegatti M, Deliliers GL.

Exp Hematol. 2010 Nov;38(11):1058-65. doi: 10.1016/j.exphem.2010.07.005. Epub 2010 Jul 22.

PMID:
20655352
48.

Effect of prothrombin 19911 A>G polymorphism on the risk of cerebral sinus-venous thrombosis.

Martinelli I, Bucciarelli P, De Stefano V, Passamonti SM, Menegatti M, Tormene D, Tosetto A, Mannucci PM.

Eur J Neurol. 2010 Dec;17(12):1482-5. doi: 10.1111/j.1468-1331.2010.03068.x.

PMID:
20482605
49.

Factor X deficiency.

Menegatti M, Peyvandi F.

Semin Thromb Hemost. 2009 Jun;35(4):407-15. doi: 10.1055/s-0029-1225763. Epub 2009 Jul 13. Review.

PMID:
19598069
50.

Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management.

Peyvandi F, Palla R, Menegatti M, Mannucci PM.

Semin Thromb Hemost. 2009 Jun;35(4):349-55. doi: 10.1055/s-0029-1225757. Epub 2009 Jul 13.

PMID:
19598063

Supplemental Content

Loading ...
Support Center